The assay is part of our comprehensive service package to test compounds in preclinical disease models. It also benefits from our unique in chip histology approach that enables low-manipulation histology assessments of 3D micro-tissues.
Immunofluorescent staining of HER2 and nuclei. Arrows indicate expected membrane localization of HER2.
Furthermore, the 3D CoSeedis™ Drug Penetration Assay can be performed in parallel to the corresponding 3D CoSeedis™ Dose Response Assay and therefore consolidates the data from dosage and penetration from the same micro-tissue, a high-content multiplex feature unique on the market.
Key features of the 3D CoSeedis™ Drug Penetration Assay:
Low-manipulation one-step penetration assessment
Multiplexing of dosage and penetration data
Multi-drug treatments possible
Would you like to know more about the unique 3D CoSeedis™ in chip assays? I am happy to answer all your questions and I am looking forward to receiving your call.